Regeneron Pharmaceuticals Inc (REGN)

Gross profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Gross profit	US$ in thousands	10,977,900	10,203,900	9,724,400	13,718,000	7,040,600
Revenue	US$ in thousands	14,202,000	13,044,200	12,113,500	16,014,400	8,440,200
Gross profit margin		77.30%	78.23%	80.28%	85.66%	83.42%

December 31, 2024 calculation

Gross profit margin = Gross profit ÷ Revenue
= $10,977,900K ÷ $14,202,000K
= 77.30%

Regeneron Pharmaceuticals Inc's gross profit margin has shown a generally positive trend over the years, starting at 83.42% in December 31, 2020 and reaching its peak at 85.66% by December 31, 2021. However, there has been a slight decline in the following years, with the margin dropping to 80.28% by December 31, 2022, further decreasing to 78.23% by December 31, 2023, and ultimately falling to 77.30% by December 31, 2024. This downward trend indicates potential challenges in managing production costs or pricing strategies, which may require attention to maintain profitability levels.